By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
It has been a mixed year for Caris Life Sciences, Inc. insiders: $1.6 million bought by four people and $28.9 million sold by four, so more selling than buying overall.
HALBERT JON (Director) made the biggest buy, worth around $990,000. Notably, at least one C-suite executive was among the buyers.
Last full quarter: net selling by insiders. Insiders bought in 3 of the last 7 full quarters. On the institutional side, 246 funds reported holding CAI at the end of Q2 2026, and more funds bought than sold.
Are insiders buying or selling CAI stock?
In the last 12 months Caris Life Sciences, Inc. insiders made open-market purchases worth about $1.6 million and sales worth about $28.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in CAI?
The most recent open-market insider trade in CAI was filed on 2026-09-23.
How many institutions own CAI?
246 investment managers reported holding CAI in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded CAI?
No congressional trades in CAI were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).